+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years - 99Years
FEMALE
ID06749600

Clinical Study of Primary Ovarian Leiomyosarcoma Management and Outcomes Including Patients Aged 18 to 99 Years

Led by Azienda USL Reggio Emilia - IRCCS · Updated on 2026-05-05

30

Participants Needed

10

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting an observational study to collect detailed data on primary ovarian leiomyosarcoma POLMS, a very rare and aggressive type of ovarian cancer. This study includes both past cases diagnosed since 1980 and newly identified cases, aiming to expand knowledge from a previously described group of 113 cases. The goal is to find patterns in diagnosis, treatment, and outcomes to help establish guidelines for managing this rare cancer. The study uses a national, multicenter design with retrospective and prospective data collection. Information is gathered through clinical case reviews and institutional archives, standardized via electronic case report forms on REDCap. The data collected covers patient demographics, tumor features, treatment details including surgery and therapies, recurrence, survival outcomes, and immunohistochemical markers. All information undergoes thorough validation to ensure consistency across centers. Participants provide data through medical records rather than active treatment. Researchers analyze tumor markers like CA-125 and Ki-67, treatment types, and patient outcomes including disease-free and overall survival. The main measurement is the relationship between treatment approaches and prognosis over a 3-year observation period. The study respects patient confidentiality by reporting aggregated results and spans adult female patients aged 18 to 99 years.

CONDITIONS

Brief Title

Clinical Management and Outcomes of Primary Ovarian Leiomyosarcoma

Research Team

V

Vincenzo Dario Mandato, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here